‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long - The Washington Post
Source:The Washington Post
The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for treating the stubbornly lethal disease.
Related Articles
Why Don’t Humans Have A Mating Season? An Evolutionary Biologist Explains - Forbes
Humans don’t have a defined mating season like deer or wolves. Here’s how evolution blended biology, …
Stop Popping Pills Without Thinking - COLlive
Spring has long sprung, and our allergies are in full swing. Luckily, modern medicine has plenty of …
Vegetarians have lower risk of five cancers, study finds - Financial Times
Meat-eaters have a higher chance of developing cancers of the breast, prostate and kidney, …
A respiratory virus is spiking in N.J. right now that you’ve probably never heard of - NJ.com
Cases are increasing across the country and in New Jersey.